• 제목/요약/키워드: 2-Hydroxy-1-naphthyl

검색결과 8건 처리시간 0.029초

N'-[(2-Hydroxy-1-naphthyl)methylene]arylhydrazide 화합물의 HIF-2α 저해 활성 (N'-[(2-Hydroxy-1-naphthyl)methylene]arylhydrazides as Potent HIF-2α Inhibitors)

  • 이효성
    • 한국융합학회논문지
    • /
    • 제13권1호
    • /
    • pp.161-166
    • /
    • 2022
  • HIF-2α는 저산소 조건에서 활성화되는 전사인자로 암, 대사증후군, 관절염, 간염 등의 발병 기전에서 핵심 역할을 한다고 보고된 바 있다. 이에 HIF-2α 저해제를 도출하고자 기존 약리활성 구조를 도입한 N'-arylisonicotinolyhydrazide를 골격으로 설정하고 화합물 라이브러리로부터 해당 화합물들을 선택하여 HIF-2α 저해활성을 측정하였다. 이를 위해 HRE-luciferase를 HTB-94세포에 transfection하고 아데노바이러스를 이용하여 HIF-2α를 세포 내로 도입하여 luciferase reporter gene assay를 수행하였다. 2-hydroxy-1-naphthyl 기를 포함한 화합물에서 저해활성이 발견됨에 따라 이 구조를 포함하는 골격을 다시 설정하고 해당 화합물들을 선정하여 활성을 측정하였다. 그 결과 HIF-2α 저해활성과 위양성 시험을 통하여 2 종의 HIF-2α 저해제를 도출하였다. 본 연구는 생물학과 화학의 융합연구로 수행되었으며 도출된 저해제는 후속 저해제 탐색 연구와 HIF-2α의 기능 연구에 활용될 수 있고 관련 질환의 치료제 개발에도 기여 할 것으로 사료된다.

Synthesis of 4-Hydroxycoumarion Derivatives-1: An Efficient Synthesis of Flocoumafen

  • Park, Oee-Sook;Jang, Bong-Suek
    • Archives of Pharmacal Research
    • /
    • 제18권4호
    • /
    • pp.277-281
    • /
    • 1995
  • An anticoagulant, 4-hydroxy-3-[1, 2, 3, 4-tetrahydro-3-[4-(4-trifluoromethylbenzyloxy)phenyll-1 -naphthyl]coumarin (Flocoumafen) was synthesized in 8 steps starting from phenylacetyl shloride and anisole. The key step in the synthesis involves the reaction of 3-(4-methoxyphenyl)-1-teralol with 4-hydroxycoumarin to give 4-hydroxy-3 [1, 2, 3, 4-tetrahydro-3-[4-emthoxyphenyl]-1-naphthyl]coumarin.

  • PDF

Synthesis of 4-Hydroxy-1-thiocounmarin Derivatives-1 : An Efficient Synthesis of Thioflocoumafen

  • Jung, Jae-Chul;Kim, Ju-Cheun;Park, Oee-Sook;Jang, Bong-Suek
    • Archives of Pharmacal Research
    • /
    • 제22권3호
    • /
    • pp.302-305
    • /
    • 1999
  • An efficient procedure for the preparation of 4-hydroxy-3-{1,2,3,4-tetra-hydro-3-[4-(4-trifluoromethylbenzyloxy)phenyl]-1-naphthyl}thiocoumarin (thioflocoumafen, 1a and 1b) is described. The key step in the synthesis involves the condensation reaction of 3-(4-methoxyphenyl)-1-tetralol (2) with 4-hydroxy-1-thiocoumarin (3).

  • PDF

Bulky Side Group을 갖는 폴리벤즈이미다졸의 합성 (Synthesis of Polybenzimidazole Containing Bulky Side Group)

  • 안병현;김원호
    • 폴리머
    • /
    • 제25권6호
    • /
    • pp.796-802
    • /
    • 2001
  • 나프탈렌을 측쇄로 갖는 새로운 폴리벤즈이미다졸 단량체을 합성하고, 이 단량체를 친핵치환반응에 의해 중합하였다. 4-Methoxy-N-naphthyl-1,2-phenylenediamine과 4-fluoro-benzoyl chloride의 반응으로 N-(4-fluorobenzoyl)-4-methoxy-N'-naphthyl-1,2-phenyl-enediamine이 합성되었고 이로부터 고리화반응 및 demethylation에 의해 단량체인 2-(4-fluoro-benzoyl)-5-hydroxy-1-naphthylbenzimidazole이 얻어졌다. 중합반응은 potassium carbonate를 함유하는 N-cyclohexyl-2-pyrrolidinone (CHP)에서 행해졌다. 생성된 폴리벤즈이미다졸은 N-methyl-2-pyrrolidinone (NMP)에 용해되었고 0.38 dL/g (NMP at $30^{\circ}C$)의 대수 점도를 가졌다. 유리전이온도($T_g$)는 $270^{\circ}C$였고 열중량분석에서 5% 중량감소를 보이는 온도는 질소분위기에서는 $550^{\circ}C$, 공기중에서는 $540^{\circ}C$였다.

  • PDF

Synthesis, Antioxidant Activity and Fluorescence Properties of Novel Europium Complexes with (E)-2- or 4-hydroxy-N'-[(2-hydroxynaphthalen-1-yl)methylene]benzohydrazide Schiff Base

  • Liu, Lijun;Alam, Mohammad Sayed;Lee, Dong-Ung
    • Bulletin of the Korean Chemical Society
    • /
    • 제33권10호
    • /
    • pp.3361-3367
    • /
    • 2012
  • Two novel Eu(III) complexes with notable properties have been successfully prepared with hydrazone Schiff base ligands, (E)-2-hydroxy-N'-[(2-hydroxynaphthalen-1-yl)methylene]benzohydrazide (3a) and (E)-4-hydroxy-N'-[(2-hydroxynaphthalen-1-yl)methylene]benzohydrazide (3b). DFT, FMO energy and Mulliken charge distribution studies of the ligands allowed us to hypothesize that their HC=N, > C=O and -OH (naphthyl) groups were involved in coordinating with the $Eu^{3+}$ ion. The eight coordination sites of the $Eu^{3+}$ ion were occupied by the three functional groups of the two ligands (3a or 3b) mentioned above and two water molecules. Similar UV, IR and fluorescence spectra indicated the presence of comparable coordination environments for the $Eu^{3+}$ ion in both complexes. Both the ligands and their complexes exhibited moderate DPPH radical scavenging activity. Moreover, it was found that the Eu(III) complexes exhibited fluorescence properties.

엑시플렉스 현상을 이용한 백색 유기발광소자의 전하수송 메커니즘

  • 권원주;이광섭;김태환
    • 한국진공학회:학술대회논문집
    • /
    • 한국진공학회 2011년도 제41회 하계 정기 학술대회 초록집
    • /
    • pp.321-321
    • /
    • 2011
  • 유기발광소자는 낮은 구동전압, 높은 명암비 및 높은 색 재현성 등의 장점을 바탕으로 차세대 디스플레이 및 조명용 광원으로 주목 받고 있다. 또한, 유기발광소자는 발광층을 다층으로 적층하여 적색, 녹색 및 청색을 동시에 발광시켜 단일 소자로 백색 발광소자를 제작할 수 있는 특성을 가지고 있다. 본 연구에서는 백색 유기발광소자를 제작하기 위하여 두 유기물 사이에서 나타나는 엑시플렉스 현상을 이용하였다. 엑시플렉스 현상으로 인한 발광 특성 변화를 관찰하기 위하여 낮은 highest occupied molecular orbital에너지 준위를 가지는 4,4',4''-tris(2-methylphenyl-phenylamino)triphenylamine (m-MTDATA)를 tris(8-hydroxy-quinolinato)aluminum 또는 N,N'-bis(1- naphthyl)-N,N'-diphenyl-1,1'-biphenyl-4,4'-diamine과 혼합하여 발광층을 제작하였다. 엑시플렉스 현상을 관측하기 위해 제작된 유기발광소자의 전기적 및 광학적 특성을 측정한 결과 엑시플렉스 현상으로 인한 발광 특성의 변화가 나타났으며 인가된 전압에 따라 엑시플렉스 현상의 변화를 확인하였다. 엑시플렉스 현상을 이용한 백색 유기발광소자를 제작하기 위하여 4-(dicyanomethylene)-2-methyl-6-(p-dimethyl aminostyryl)-4H-pyran (DCM1)을 9,10-di(2-naphthyl)anthracene층과 m-MTDATA층 사이에 얇게 삽입하여 발광층을 형성하였다. 제작된 백색 유기발광소자의 전기적 및 광학적 특성을 측정한 결과 DCM1이 엑시플렉스 현상을 이용하여 적색 빛을 발광하는 것을 알 수 있었다. 본 연구는 엑시플렉스 현상을 이해하고 응용하는데 많은 도움을 준다.

  • PDF

Identification of urinary metabolite(s) of CKD-712 by gas chromatography/mass spectrometry in rats

  • Jeon, Hee-Kyung;Park, Hae-Yeon;Kim, Youn-Jung;Kwon, Oh-Seung;Ryu, Jae-Chun
    • 한국환경독성학회:학술대회논문집
    • /
    • 한국환경독성학회 2003년도 춘계학술대회
    • /
    • pp.188-188
    • /
    • 2003
  • Examination was made of the urinary metabolite(s) of CKD-712, which is a chiral compound, named S-YS49 derived from higenamine (one component of Aconite spp.) derivatives. First of all, to analyze the metabolite(s) of CKD-712, a simple and sensitive detection method for CKD-712 was developed by using gas chromatography-mass spectrometry GC/MS). Urine was collected from adult male Sprague-Dawley rats 250${\pm}$10g) in metabolic cage for 24hr after oral administration of 100 mg/kg of CKD-712. The recovery of CKD-712 after extraction and concentration with AD-2 resin column was above 90 % from rat urine. The detection limits of CKD-712 in urine was approximately 0.1 ng/mL. It has well been suggested that isoquinoline possessing catechol moiety such as CKD-712 should be subjected to the catechol-O-methyl kransferase activity in vivo. We detected three major peaks of presumed CKD-712 metabolites in the total ion chromatogram obtained from the rat urine sample after oral administration of CKD-712. From these results, it is assumed that the urinary metabolites are mono-methylation in the naphthyl moiety (metabolite I ), methylation at the C-6 or 7 hydroxy group in the isoquinoline moiety and hydroxylation at in the naphthyl moiety (metaboliteII), and methylation at the C-6 or 7 hydroxy group in the isoquinoline moiety (metaboliteIII).

  • PDF

Liquid-liquid Distribution of the Tetravalent Zirconium, Hafnium and Thorium with a New Tetradentate Naphthol-derivative Schiff Base

  • Saberyan, Kamal;Shamsipur, Mojtaba;Zolfonoun, Ehsan;Salavati-Niasari, Masoud
    • Bulletin of the Korean Chemical Society
    • /
    • 제29권1호
    • /
    • pp.94-98
    • /
    • 2008
  • A fundamental study was developed concerning the novel solvent extraction of the tetravalent metal ions; zirconium(IV), hafnium(IV) and thorium(IV). Their extraction behavior in toluene was investigated with a recently synthesized naphthol-derivative Schiff base, 1-({[4-(4-{[(E)-1-(2-hydroxy-1-naphthyl)methyliden]amino}phenoxy) phenyl]imino}methyl)-2-naphthol (HAPMN). The spectrophotometrical examination of the complex formation between HAPMN and the Zr(IV), Hf(IV) and Th(IV) ions in acetonitrile revealed the formation of stable 1:1 complexes in the solution. After the thorium extraction in toluene, it was found that [Th(OH)3HA] was the respective deriving substance. While, in the case of zirconium and hafnium extraction, the extracted adduct was found to be [M4(OH)8(H2O)16Cl62HA]. The stoichiometric coefficients of these extracted species were determined by the slope analysis method. The extraction reaction followed a cation exchange mechanism.